Archives: 2021-02-03

PIER MARIA FORNASARI
2021-02-03

Crucial role of social media in disseminating health information and tackling infodemics and misinformation in the time of COVID-19

With the onset of the COVID-19 pandemic, social media has rapidly become a crucial communication tool for information generation, dissemination, and consumption. In this scoping review, were selected and examined peer-reviewed empirical studies relating to COVID-19 and social media during the first outbreak from November, 2019, to November, 2020. From an analysis of 81 studies,

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-02-03

Heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac “Sputnik V” Found 91,6% Effective Against COVID-19: a study published on The Lancet shows

A Russian vaccine against COVID-19 — Gam-COVID-Vac (dubbed “Sputnik V”) — shows 92% efficacy in interim results from a phase 3 trial reported in The Lancet. The two-dose vaccine uses replication-deficient adenoviruses to deliver a SARS-CoV-2 glycoprotein as the antigenic stimulus. Doses are administered at 21-day intervals, and the vaccine may be stored in normal freezers.

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-02-03

The timing of the booster dose is determinant for improval of immunogenicity and efficacy of ChAdOx1 (Oxford Astra Zeneca ) nCoV-19 (AZD1222) vaccine

The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, MHRA, with a regimen of two standard doses given with an interval of between 4 and 12 weeks. The planned rollout in the UK will involve vaccinating people in high risk categories with their first dose immediately, and delivering

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-02-01

Covid-19: B.1.1.7 new UK variant patients present more commonly sore throat, fatigue, and myalgia for Office for National Statistics

People infected with the new variant of covid-19 discovered in the South East of England (known as B.1.1.7 or VUI 202012/01) are more likely to have a cough, sore throat, fatigue, or myalgia than those infected with other variants, the Office for National Statistics has reported. The data, published 27 January, also show that people

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-02-01

Arizona University Researchers Develop Smartphone-Based COVID-19 test that uses a smartphone microscope and could deliver results in about 10 minutes.

Researchers at the University of Arizona are developing a COVID-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes. The UArizona research team, led by biomedical engineering professor Jeong-Yeol Yoon, aims to combine the speed of existing nasal swab antigen tests with the high accuracy of nasal swab PCR,

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2021-02-01

33% can be the proportion of SARS-CoV-2 Infections That Are Asymptomatic for a Systematic Review

In the 14 studies with longitudinal data that reported information on the evolution of symptomatic status, nearly three quarters of persons who tested positive but had no symptoms at the time of testing remainedasymptomatic. Current data suggest that infected persons without symptoms—including both presymptomatic and asymptomatic persons—account for more than 40% of all SARS-CoV-2 transmission.

Read More

No Comments InCovid-19 Uncategorized